Joint press release by WACKER and CordenPharma: Use of Artificial Intelligence in Drug Development: WACKER, CordenPharma, LMU and HU Berlin Train Machine Learning Algori
Munich, Plankstadt and Berlin, March 30, 2023 – Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), Wacker Chemie AG and CordenPharma International GmbH have launched a project to accelerate the development of RNA-based drugs. The aim is to develop a new generation of lipid nanoparticles (LNPs), which are a key component of RNA-based pharmaceuticals. Based on these formulations, a machine learning algorithm is to be trained that automatically identifies the best constituents for new RNA formulations – as yet a particularly time-